Newspaper Publication on Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026
CAMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The filing is a regulatory intimation under SEBI Listing Regulation 47, informing BSE and NSE that Jyothy Labs Limited's audited financial results for Q4 and FY ended March 31, 2026 were published in Business Standard and Maalaimurasu on May 5, 2026. The results were reviewed by the Audit Committee and approved by the Board of Directors on May 4, 2026. Total income grew to ₹71,741 lakh in Q4 and ₹2,94,429 lakh for the full year, up from ₹66,596 lakh and ₹2,84,392 lakh respectively year-on-year. However, net profit after tax declined — from ₹7,700 lakh to ₹6,752 lakh in Q4 and from ₹37,117 lakh to ₹33,319 lakh for FY26. EPS fell to ₹9.07 from ₹10.11 year-on-year. The Board has recommended a final dividend of ₹3.50 per equity share of ₹1 each, subject to shareholder approval. Note 3 states that following the sale of the only subsidiary (Jyothy Kallol Bangladesh Limited) in March 2025, the company now presents only standalone results.
Profit after tax declined about 10% year-on-year despite a 3.5% rise in total income, which may be viewed negatively by shareholders. The dividend recommendation of ₹3.50 per share provides some shareholder reward. The shift to standalone-only reporting is a structural change following the Bangladesh subsidiary sale.